george church

Rejuvenate Bio spun out of my lab at Harvard, and I co-founded it. One injection reverses cardiac disease in dogs, with three years of safety data and zero safety issues. They’ve raised $3.2M+ and 1,250+ investors are in, and Kingscrowd ranks the round #1 in the country. It closes soon: wefunder.com/rejuvenatebio

Please join me at ARDD 2026, the leading conference on Aging Research and Drug Discovery. At the beautiful Harvard Rubenstein Treehouse October 1–3, 2026. Scientists, biotech pioneers, pharmaceutical executives, investors, and policymakers advancing longevity science. Registration: agingpharma.org#ARDD2026 #AgingResearch #DrugDiscovery

you should consider joining. Great team.

I co-founded @RejuvenateBio and have watched this platform earn every milestone. @Merck Animal Health, the second largest animal health company in the world, just invested in their $6M round and inked a strategic R&D partnership.

The science earned it: cardiac disease reversal in dogs, three years of safety, no safety signals.

Now the biotech community can invest alongside Merck and secure equity at this early stage. Rejuvenate Bio is raising on @Wefunder. @Kingscrowd ranked it the #2 Reg CF deal in the country.

$7M+ raised. Investments range from $250 to $100K+. The round is now oversubscribed, but you can still get in.

wefunder.com/rejuvenatebio